Comprehensive Stock Comparison

Compare Nomura Holdings, Inc. (NMR) vs Piper Sandler Companies (PIPR) Stock

Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.

Tickers 2 / 10100+ Metrics

Selected Stocks

Add up to 10 tickers. Use presets or search to get started.

2 / 10
Try these comparisons:

Quick Verdict

CategoryWinnerWhy
GrowthNMR13.4% revenue growth vs PIPR's 13.1%
ValueNMRLower P/E (11.3x vs 15.3x), PEG 1.04 vs 2.61
Quality / MarginsPIPR12.2% net margin vs NMR's 7.6%
Stability / SafetyNMRBeta 1.19 vs PIPR's 1.53
DividendsNMR2.6% yield, 2-year raise streak, vs PIPR's 1.4%
Momentum (1Y)NMR+45.9% vs PIPR's +4.0%
Efficiency (ROA)PIPR10.7% ROA vs NMR's 0.6%, ROIC 11.0% vs 1.0%
Bottom line: NMR leads in 5 of 7 categories, making it the stronger pick for investors who prioritize growth and revenue expansion and valuation and capital efficiency. Piper Sandler Companies is the better choice for profitability and margin quality and operational efficiency and capital deployment. As direct sector peers, they can serve as alternatives in the same portfolio allocation.

Who Each Stock Is For

Income & stability

Growth exposure

Long-term compounding (10Y)

Sleep-well-at-night portfolio

Valuation efficiency (growth/$)

Defensive / Recession hedge

Business Model

What each company does and how it makes money

NMRNomura Holdings, Inc.
Financial Services

Nomura Holdings is a Japanese financial services conglomerate that operates as a full-service investment bank and securities firm. It generates revenue primarily through its Wholesale segment — investment banking, trading, and securities underwriting — which contributes roughly 60-70% of total revenue, supplemented by Retail brokerage and Investment Management services. The company's key advantage is its dominant position in Japan's domestic capital markets and its extensive Asian franchise, which provides deep client relationships and local market expertise.

PIPRPiper Sandler Companies
Financial Services

Piper Sandler Companies is an investment bank and institutional securities firm serving corporations, governments, and institutional investors. It generates revenue primarily from investment banking advisory fees — including M&A and capital raising — and institutional sales and trading commissions across equity and fixed income products. The firm's competitive advantage lies in its specialized sector expertise — particularly in municipal finance and middle-market advisory — and its long-standing client relationships in niche markets.

Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

NMRNomura Holdings, Inc.
FY 2025
Brokerage Commissions
77.6%$264.5B
Other Commissions
22.4%$76.4B
PIPRPiper Sandler Companies
FY 2024
Advisory Services
53.7%$809M
Equity Sales and Trading
14.3%$215M
Fixed Income Sales and Trading
12.4%$186M
Corporate Financing
11.5%$174M
Municipal Financing
8.1%$123M

Financial Metrics Comparison

Side-by-side fundamentals across 2 stocks. BestLagging

Financial Scorecard

NMR 4PIPR 2
Financial MetricsPIPR5/5 metrics
Valuation MetricsNMR5/6 metrics
Profitability & EfficiencyPIPR9/9 metrics
Total ReturnsNMR4/6 metrics
Risk & VolatilityNMR2/2 metrics
Analyst OutlookNMR2/2 metrics

NMR leads in 4 of 6 categories (Valuation Metrics, Total Returns). PIPR leads in 2 (Financial Metrics, Profitability & Efficiency).

Financial Metrics (TTM)

NMR is the larger business by revenue, generating $4.51T annually — 3042.4x PIPR's $1.5B. Profitability is closely matched — net margins range from 12.2% (PIPR) to 7.6% (NMR).

MetricNMRNomura Holdings, …PIPRPiper Sandler Com…
RevenueTrailing 12 months$4.51T$1.5B
EBITDAEarnings before interest/tax$533.0B$294M
Net IncomeAfter-tax profit$370.1B$236M
Free Cash FlowCash after capex$0-$19M
Gross MarginGross profit ÷ Revenue+36.9%+99.6%
Operating MarginEBIT ÷ Revenue+10.5%+14.7%
Net MarginNet income ÷ Revenue+7.6%+12.2%
FCF MarginFCF ÷ Revenue-19.3%+20.1%
Rev. Growth (YoY)Latest quarter vs prior year
EPS Growth (YoY)Latest quarter vs prior year-5.5%+72.4%
PIPR leads this category, winning 5 of 5 comparable metrics.

Valuation Metrics

At 12.7x trailing earnings, NMR trades at a 56% valuation discount to PIPR's 28.9x P/E. Adjusting for growth (PEG ratio), NMR offers better value at 1.16x vs PIPR's 4.92x — a lower PEG means you pay less per unit of expected earnings growth.

MetricNMRNomura Holdings, …PIPRPiper Sandler Com…
Market CapShares × price$26.6B$4.9B
Enterprise ValueMkt cap + debt − cash$192.1B$4.6B
Trailing P/EPrice ÷ TTM EPS12.66x28.86x
Forward P/EPrice ÷ next-FY EPS est.11.35x15.32x
PEG RatioP/E ÷ EPS growth rate1.16x4.92x
EV / EBITDAEnterprise value multiple56.19x18.58x
Price / SalesMarket cap ÷ Revenue0.92x3.34x
Price / BookPrice ÷ Book value/share1.20x3.69x
Price / FCFMarket cap ÷ FCF16.61x
NMR leads this category, winning 5 of 6 comparable metrics.

Profitability & Efficiency

PIPR delivers a 16.2% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $10 for NMR. PIPR carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to NMR's 8.75x. On the Piotroski fundamental quality scale (0–9), PIPR scores 8/9 vs NMR's 7/9, reflecting strong financial health.

MetricNMRNomura Holdings, …PIPRPiper Sandler Com…
ROE (TTM)Return on equity+10.3%+16.2%
ROA (TTM)Return on assets+0.6%+10.7%
ROICReturn on invested capital+1.0%+11.0%
ROCEReturn on capital employed+2.1%+10.3%
Piotroski ScoreFundamental quality 0–978
Debt / EquityFinancial leverage8.75x0.07x
Net DebtTotal debt minus cash$25.83T-$384M
Cash & Equiv.Liquid assets$5.51T$483M
Total DebtShort + long-term debt$31.35T$99M
Interest CoverageEBIT ÷ Interest expense0.20x51.76x
PIPR leads this category, winning 9 of 9 comparable metrics.

Total Returns (with DRIP)

A $10,000 investment in PIPR five years ago would be worth $28,749 today (with dividends reinvested), compared to $16,957 for NMR. Over the past 12 months, NMR leads with a +45.9% total return vs PIPR's +4.0%. The 3-year compound annual growth rate (CAGR) favors NMR at 33.4% vs PIPR's 26.9% — a key indicator of consistent wealth creation.

MetricNMRNomura Holdings, …PIPRPiper Sandler Com…
YTD ReturnYear-to-date+6.5%-15.5%
1-Year ReturnPast 12 months+45.9%+4.0%
3-Year ReturnCumulative with dividends+137.6%+104.3%
5-Year ReturnCumulative with dividends+69.6%+187.5%
10-Year ReturnCumulative with dividends+160.8%+681.5%
CAGR (3Y)Annualised 3-year return+33.4%+26.9%
NMR leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

NMR is the less volatile stock with a 1.19 beta — it tends to amplify market swings less than PIPR's 1.53 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NMR currently trades 93.9% from its 52-week high vs PIPR's 77.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricNMRNomura Holdings, …PIPRPiper Sandler Com…
Beta (5Y)Sensitivity to S&P 5001.19x1.53x
52-Week HighHighest price in past year$9.58$380.26
52-Week LowLowest price in past year$4.86$202.91
% of 52W HighCurrent price vs 52-week peak+93.9%+77.7%
RSI (14)Momentum oscillator 0–10053.139.9
Avg Volume (50D)Average daily shares traded1.1M119K
NMR leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Wall Street rates NMR as "Hold" and PIPR as "Hold". Consensus price targets imply 32.5% upside for PIPR (target: $392) vs -35.7% for NMR (target: $6). For income investors, NMR offers the higher dividend yield at 2.61% vs PIPR's 1.41%.

MetricNMRNomura Holdings, …PIPRPiper Sandler Com…
Analyst RatingConsensus buy/hold/sellHoldHold
Price TargetConsensus 12-month target$5.79$391.50
# AnalystsCovering analysts911
Dividend YieldAnnual dividend ÷ price+2.6%+1.4%
Dividend StreakConsecutive years of raises20
Dividend / ShareAnnual DPS$36.70$4.17
Buyback YieldShare repurchases ÷ mkt cap+1.4%+1.3%
NMR leads this category, winning 2 of 2 comparable metrics.

Historical Charts

Charts are rendered on first load. Hover for details.

Chart 1Total Return — 5 Years (Rebased to 100)

StockMar 20Feb 26Change
Nomura Holdings, In… (NMR)100188.21+88.2%
Piper Sandler Compa… (PIPR)100462.64+362.6%

Piper Sandler Compa… (PIPR) returned +187% over 5 years vs Nomura Holdings, In… (NMR)'s +70%. A $10,000 investment in PIPR 5 years ago would be worth $28,749 today (including dividends reinvested).

Chart 2Revenue Growth — 10 Years

Stock20162025Change
Nomura Holdings, In… (NMR)$1.6T$4.5T+187.9%
Piper Sandler Compa… (PIPR)$762M$1.5B+94.3%

Nomura Holdings, Inc.'s revenue grew from $1.6T (2016) to $4.5T (2025) — a 12.5% CAGR.

Chart 3Net Margin Trend — 10 Years

Stock20162025Change
Nomura Holdings, In… (NMR)8.4%7.6%-10.0%
Piper Sandler Compa… (PIPR)-2.9%12.2%+524.5%

Nomura Holdings, Inc.'s net margin went from 8% (2016) to 8% (2025).

Chart 4P/E Ratio History — 9 Years

Stock20172025Change
Nomura Holdings, In… (NMR)0.10.1+0.0%
Piper Sandler Compa… (PIPR)17.729.3+65.5%

Nomura Holdings, Inc. has traded in a 0x–0x P/E range over 8 years; current trailing P/E is ~13x. Piper Sandler Companies has traded in a 10x–37x P/E range over 7 years; current trailing P/E is ~29x.

Chart 5EPS Growth — 10 Years

Stock20162025Change
Nomura Holdings, In… (NMR)35.52111.03+212.6%
Piper Sandler Compa… (PIPR)-1.7310.24+691.9%

Nomura Holdings, Inc.'s EPS grew from $35.52 (2016) to $111.03 (2025) — a 14% CAGR.

Chart 6Free Cash Flow — 5 Years

2021
$546B
$687M
2022
$-974B
$-256M
2023
$-866B
$266M
2024
$-13B
$298M
2025
$-869B
Nomura Holdings, In… (NMR)Piper Sandler Compa… (PIPR)

Nomura Holdings, Inc. generated $-869B FCF in 2025 (-259% vs 2021). Piper Sandler Companies generated $298M FCF in 2024 (-57% vs 2021).

Loading custom metrics...

NMR vs PIPR: Frequently Asked Questions

9 questions · data-driven answers · updated daily

01

Is NMR or PIPR a better buy right now?

Nomura Holdings, Inc. (NMR) offers the better valuation at 12.7x trailing P/E (11.3x forward), making it the more compelling value choice. Analysts rate Nomura Holdings, Inc. (NMR) a "Hold" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — NMR or PIPR?

On trailing P/E, Nomura Holdings, Inc. (NMR) is the cheapest at 12.7x versus Piper Sandler Companies at 28.9x. On forward P/E, Nomura Holdings, Inc. is actually cheaper at 11.3x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Nomura Holdings, Inc. wins at 1.04x versus Piper Sandler Companies's 2.61x — a reasonable growth-adjusted valuation.

03

Which is the better long-term investment — NMR or PIPR?

Over the past 5 years, Piper Sandler Companies (PIPR) delivered a total return of +187.5%, compared to +69.6% for Nomura Holdings, Inc. (NMR). A $10,000 investment in PIPR five years ago would be worth approximately $29K today (assuming dividends reinvested). Over 10 years, the gap is even starker: PIPR returned +681.5% versus NMR's +160.8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — NMR or PIPR?

By beta (market sensitivity over 5 years), Nomura Holdings, Inc. (NMR) is the lower-risk stock at 1.19β versus Piper Sandler Companies's 1.53β — meaning PIPR is approximately 28% more volatile than NMR relative to the S&P 500. On balance sheet safety, Piper Sandler Companies (PIPR) carries a lower debt/equity ratio of 7% versus 9% for Nomura Holdings, Inc. — giving it more financial flexibility in a downturn.

05

Which has better profit margins — NMR or PIPR?

Piper Sandler Companies (PIPR) is the more profitable company, earning 12.2% net margin versus 7.6% for Nomura Holdings, Inc. — meaning it keeps 12.2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PIPR leads at 14.7% versus 10.5% for NMR. At the gross margin level — before operating expenses — PIPR leads at 99.6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is NMR or PIPR more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential. By this metric, Nomura Holdings, Inc. (NMR) is the more undervalued stock at a PEG of 1.04x versus Piper Sandler Companies's 2.61x. A PEG below 1.5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Nomura Holdings, Inc. (NMR) trades at 11.3x forward P/E versus 15.3x for Piper Sandler Companies — 4.0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PIPR: 32.5% to $391.50.

07

Which pays a better dividend — NMR or PIPR?

All stocks in this comparison pay dividends. Nomura Holdings, Inc. (NMR) offers the highest yield at 2.6%, versus 1.4% for Piper Sandler Companies (PIPR).

08

Is NMR or PIPR better for a retirement portfolio?

For long-horizon retirement investors, Piper Sandler Companies (PIPR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (1.4% yield, +681.5% 10Y return). Both have compounded well over 10 years (PIPR: +681.5%, NMR: +160.8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between NMR and PIPR?

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. In terms of investment character: NMR is a mid-cap deep-value stock; PIPR is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.

💰
Stocks Like

NMR

Income & Dividend Stock

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 6%
  • Net Margin > 5%
Run This Screen
🏦
Stocks Like

PIPR

Stable Dividend Mega-Cap

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 6%
  • Net Margin > 7%
Run This Screen
Custom Screen

Better Than Both

Find stocks that beat NMR and PIPR on the metrics you choose

Net Margin>
%
(NMR: 7.6% · PIPR: 12.2%)
P/E Ratio<
x
(NMR: 12.7x · PIPR: 28.9x)